Rchr
J-GLOBAL ID:200901005606477988
Update date: Nov. 18, 2024
Kato Atsushi
カトウ アツシ | Kato Atsushi
Affiliation and department:
Homepage URL (2):
https://u-toyama.elsevierpure.com/ja/persons/atsushi-kato
,
https://u-toyama.elsevierpure.com/en/persons/atsushi-kato
Research field (4):
Pharmaceuticals - chemistry and drug development
, Pharmacology
, Pharmaceuticals - health and biochemistry
, Functional biochemistry
Research keywords (23):
glycosidase inhibitors
, 機能性食品
, 漢方薬
, chaperone
, 糖鎖プロセシング
, 和漢医薬学
, glycoprotein biosynthesis
, N-linked oligossacharide
, Pharmacological chaperone
, 小胞体品質管理機構
, folding disease
, Gaucher disease
, lysosome disease
, glycosidase
, sugar-mimic alkaloid
, 医療薬剤学
, 天然物化学
, 糖質生化学
, azasugar
, iminosugar
, Phytochemistry
, Biochemistry
, glycobiology
Research theme for competitive and other funds (24):
- 2021 - 2024 変異酵素の構造安定化に基づく機能性シャペロン化合物の創製とポンペ病治療への応用
- 2017 - 2020 テイ-サックス病治療に最適な高親和性シャペロン化合物の創製
- 2016 - 2019 角質層内セラミドの増加作用を有する合成カエデタンニンの低コスト大量生産技術の開発
- 2015 - 2018 結核菌細胞壁の構築阻害を特徴とする新規イミノ糖型治療薬のデザイン合成研究
- 2014 - 2017 変異酵素の構造安定化剤として機能するイミノ糖型シャペロンの設計と合成
- 2013 - 2016 Asymmetric syntheses of various iminofuranoses having a side chain at C1 position and their biological evaluation as enzyme inhibitors
- 2012 - 2015 フコシダーゼ、ラムノシダーゼを標的とした新規阻害剤の開発
- 2011 - 2014 Design, synthesis, and biological evaluation of iminosugars as pharmacological chaperone for Gaucher disease
- 2012 - 2013 低栄養環境下でも作用する新しい膵臓がん治療薬の開発研究<担癌マウスでのin vivo評価>
- 2010 - 2013 Inhibition activities of iminosugars against glycoprotein processing
- 2011 - 2013 Design, synthesis, and biological evaluation of novel class of iminosugar-based pharmacological chaperons for Gauchers disease
- 2011 - 2012 Catalytic enantioselective synthesis and biological evaluation of 1-C-alkyl-L-arabinoiminofuranose
- 2010 - 2012 DEVELOPMENT OF ANTITUMOR DRUGS TARGETING TUMOR MARKERALDO-KETO REDUCTASES
- 2010 - 2012 Characterization of glycosidase-inhibiting iminosugars and evaluation of their effect on glycoprotein biosynthesis
- 2009 - 2011 選択的ALR2阻害に基づく副作用発現の少ない抗がん剤の開発とその評価
- 2009 - 2011 Synthetic Studies on Marine Alkaloid of Batzellasides Directed toward Novel Antidiabetic Drug
- 2006 - 2008 Development of new concept drugs against lysosome disease base on enzyme structures stabilized effects
- 2004 - 2005 変異タンパク質の分子生物学的特性に基づいたリソソーム病治療薬の開発
- 2004 - 2005 Design of new pharmacological chaperones for lysosome disease
- 2002 - 2003 EFFECTS OF GLYCOSIDASE INHIBITORY SUGAR-MIMIC ALKALOIDS AGAINST LYSOSOME DISEASE.
- 2001 - 2001 デオキシアザシュガー類の新規合成法の開発と生物活性評価
- 1997 - Study of glycolipid lysosomal storage diseases
- Iminosugar (azasugar) glycosidase inhibitor : varsatite tools for glycobiogists
- Characterization of glycosidase-inhibiting iminosugars and evaluation of their effect on N-linked oligosaccharide processing
Show all
Papers (207):
-
Feng-Teng Gao, Ming Zhang, Yuna Shimadate, Atsushi Kato, Yi-Xian Li, Yue-Mei Jia, Chu-Yi Yu. Enantiomeric C-6 fluorinated swainsonine derivatives as highly selective and potent inhibitors of α-mannosidase and α-L-rhamnosidase: Design, synthesis and structure-activity relationship study. European Journal of Medicinal Chemistry. 2025. 282. 117031-117031
-
Feng-Teng Gao, Qing-Kun Wu, Ming Zhang, Yuna Shimadate, Gong Qian, Ying-Ying Song, Atsushi Kato, Yi-Xian Li, Yue-Mei Jia, George W.J. Fleet, et al. Design and synthesis of 6-C-alkyl-DMDP type nanomolar inhibitors of β-galactosidase and β-glucosidase based on broussonetine S and related derivatives. European Journal of Medicinal Chemistry. 2024. 275. 116570-116570
-
Yuna Shimadate, Saki Oshima, Naoto Kasamatsu, Suzuka Yamamoto, Atsumi Taguchi, Robert J. Nash, George W.J. Fleet, Takuya Okada, Naoki Toyooka, Atsushi Kato. Synthesis of 8-epi-L-swainsonine, related C6 alkylated derivatives and their α-L-rhamnosidase inhibition. Tetrahedron Letters. 2024
-
Sujit Manmode, Nazar Hussain, Oscar Javier Gamboa Marin, Atsushi Kato, José Ignacio Veytia-Bucheli, Stéphane P. Vincent, Charles Gauthier. Thioarylation of 6-Amino-2,3,6-trideoxy-d-manno-oct-2-ulosonic Acid (IminoKdo): Access to 3,6-Disubstituted Picolinates and Mechanistic Insights. Chemistry - A European Journal. 2024. 30. 12. e202303904
-
Jérôme Désiré, Zakaria Debbah, David Gueyrard, Jérôme Marrot, Yves Blériot, Atsushi Kato. Evaluation of nonnatural L-iminosugar C,C-glycosides, a new class of C-branched iminosugars, as glycosidase inhibitors. Carbohydrate Research. 2023. 532. 108903-108903
more...
MISC (30):
-
龍 伸和, 石川 雄大, 三村 泰彦, 加藤 敦, 足立 伊佐雄. P1006-23-AM 膵癌化学療法を効果的に継続するための試み : 血小板減少に対する加味掃脾湯投与による治療継続維持の可能性(がん薬物療法(他の副作用対策)2,ポスター,一般演題,医療薬学の進歩と未来-次の四半世紀に向けて-). 日本医療薬学会年会講演要旨集. 2015. 25. 433-433
-
石川 雄大, 龍 伸和, 三村 泰彦, 加藤 敦, 足立 伊佐雄. 21-8-O20-18 甲状腺癌新規治療薬「レンバチニブ」使用症例における病棟薬剤師としての介入(がん薬物療法(多職種連携),口頭発表,一般演題,医療薬学の進歩と未来-次の四半世紀に向けて-). 日本医療薬学会年会講演要旨集. 2015. 25. 215-215
-
石川 雄大, 龍 伸和, 三村 泰彦, 加藤 敦, 足立 伊佐雄. 27-P4AM-138 切除不能膵癌患者に対するFOLFIRINOX療法の導入と薬学的管理の検討(がん薬物療法(その他),一般演題(ポスター),新時代を拓く医療薬学フロンティア). 日本医療薬学会年会講演要旨集. 2014. 24. 291-291
-
小林 馨, 格谷 美奈子, 高木 昭佳, 高橋 則正, 屋木 裕太, 三村 泰彦, 加藤 敦, 足立 伊佐雄. 28-P4AM-068 Grade3の低Mg血症を繰り返しながらセツキシマブを継続した1症例(がん薬物療法(副作用対策)1,一般演題(ポスター),新時代を拓く医療薬学フロンティア). 日本医療薬学会年会講演要旨集. 2014. 24. 386-386
-
Zilei Liu, Sarah Jenkinson, George W. J. Fleet, Atsushi Kato. Fluoro azetidines and difluoro prolines from D-glucose: Inhibition of pancreatic cancer cell growth by a fluoro azetidine. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. 2014. 248
more...
Patents (19):
-
セラミド調整剤
-
セラミド含量増加剤
-
1,5-アンヒドロ-D-グルシトールの製造方法
-
インドール誘導体および血糖降下剤
-
1,5-D-アンヒドログルシトール含有コラーゲン産生促進剤
more...
Books (2):
-
Calystegine alkaloids in the potatoes and other food plants : Symposium Series No. 745/Natural and Synthetic Toxins: Biological Implications
ACS, Washington 1999
-
Calystegine alkaloids in the potatoes and other food plants : Symposium Series No. 745/Natural and Synthetic Toxins: Biological Implications
ACS, Washington 1999
Lectures and oral presentations (19):
-
Protective effects of dietary 1,5-Anhydro-D-glucitol in diabetes and metabolic syndrome.
(2015 International Chemical Congress of Pacific Basin Societies (PACIFICHEM 2015) 2015)
-
Catalytic asymmetric syntheses and biological evaluations of α-1-C-substituted L-iminofuranose derivatives as α-glucosidase inhibitor.
(2015 International Chemical Congress of Pacific Basin Societies (PACIFICHEM 2015) 2015)
-
In silico study on the interaction of high affinity ligand calystegine B2 with β-glucocerebrosidase.
(2015 International Chemical Congress of Pacific Basin Societies (PACIFICHEM 2015) 2015)
-
Rare sugars as potential inducers of the rhamnose operon: Biotechnology and chemistry in the production of 6-deoxy-hexoses and related monosaccharides.
(2015)
-
Synthesis and interactions of rhamnose iminosugar mimics with the rhamnose operon, rhamnosidases, and rhamnose isomerase.
(2015)
more...
Professional career (1):
Committee career (3):
- 2008 - 2010 日本病院薬剤師会 地域編集委員
- 2007 - 和漢医薬学会 評議員
- 2007 - Medical and Pharmaceutical Society for WAKAN-YAKU Member of the Board of Councilors
Awards (8):
- 2014 - 日本東洋医学会北陸支部奨励賞
- 2012 - Tetrahedron: Asymmetry: Top-25 Most Cited Articles 2010-2011 Award (Elsevier)
- 2009 - The Journal of Agricultural and Food Chemistry: Most active reviewers 2008-2009 Award (American Chemical Society)
- 2009 - Bioorganic & Medicinal Chemistry: Most Cited Paper 2006-2009 Award (Elsevier)
- 2009 - The Journal of Agricultural and Food Chemistry: Most active reviewers 2008-2009 Award (The American Chemical Society)
- 2009 - Bioorganic & Medicinal Chemistry: Most Cited Paper 2006-2009 Award (Elsevier)
- 2007 - 和漢医薬学会奨励賞
- 2007 - Tetrahedron: Asymmetry Most Cited Paper 2004-2007 Award (Elsevier)
Show all
Association Membership(s) (11):
日本医療薬学会
, 日本東洋医学会
, 和漢医薬学会
, 日本病院薬剤師会
, 日本糖質学会
, 日本薬学会
, Japanese Society of Pharmaceutical Health Care and Sciences
, Medical and Pharmaceutical Society for WAKAN-YAKU
, Japanese Society oh Hospital Pharmacists
, The Japanese Society of Carbohydrate Research
, The Pharmaceutical Society of Japan
Return to Previous Page